MicroRNA-144-3p Promotes Erastin-Induced Ferroptosis by Targeting SLC7A11 in NSCLC Cells

Zhucheng Yin, Hongli Xu, Yanli Nie, Ping Lu, Yifei Ma, Xin Liang, Lingyi Xiong, Xiangchen Zhang, Shaozhong Wei, Xinjun Liang

Article ID: 6975
Vol 36, Issue 5, 2022
DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.20223605.149
Received: 8 November 2022; Accepted: 8 November 2022; Available online: 8 November 2022; Issue release: 8 November 2022

Abstract

Background: Non-small cell lung cancer (NSCLC) is the most frequent cause of malignancy-associated mortality worldwide. Ferroptosis is involved in tumorigenesis and metastasis of various cancers. Research showed that microRNA-144-3p (miR-144-3p) has regulatory impacts in NSCLC. However, the mechanism of this regulation is still unknown. Methods: Realtime quantitative polymerase chain reaction (RT-PCR) was applied to examine the level of miR-144-3p in NSCLC cells. MiR-144-3p overexpression plasmid was designed and constructed. Cell Counting Kit-8 (CCK-8) was conducted to assess the cell cytotoxicity. The malondialdehyde (MDA), reactive oxygen species (ROS), extracellular iron contents and glutathione (GSH) levels were estimated through enzyme-linked immunosorbent assay (ELISA) and flow cytometry. RNA (ribonucleic acid) pulldown and luciferase reporter assays were applied to assess the interaction between miR-144-3p and solute carrier family 7 member 11 (SLC7A11). Results: The study showed down-regulation of miR-144-3p in NSCLC clinical tissues and cells. MiR-144-3p overexpression significantly enhanced cytotoxicity induced by Erastin in NCI-H23 and NCI-H1650 cells. Further studies demonstrated that miR-144-3p overexpression accelerated the MDA, ROS and extracellular iron contents while inhibited GSH level in NCI-H23 cells treated with Erastin. Moreover, the luciferase reporter and RNA pulldown assay unveiled that SLC7A11 was a downstream target of miR-144-3p. Overexpression of SLC7A11 effectively reversed lipid peroxidation and cell cytotoxicity induced by miR-144-3p overexpression. Conclusions: To summarize, this study provided evidences on the functions and mechanism of ferroptosis activated by miR-144-3p and revealed that miR-144-3p might be a novel potential application for NSCLC patients.


Keywords

miR-144-3p;SLC7A11;Erastin;ferroptosis;non-small-cell lung carcinoma (NSCLC)


References

Supporting Agencies



Copyright (c) 2022 Zhucheng Yin, Hongli Xu, Yanli Nie, Ping Lu, Yifei Ma, Xin Liang, Lingyi Xiong, Xiangchen Zhang, Shaozhong Wei, Xinjun Liang




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).